Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Jeff J GuoChristina M L Kelton

Abstract

This study measured the treatment cost of bipolar disorder (BPD), decomposed the cost into that portion which was directly BPD-related and that attributable to comorbidities, and compared health-care utilization and costs across groups of patients with different drug regimens. Using a multistate managed-care-organization claims database, a cohort of 67,862 BPD patients were selected and followed for the length of their enrollment between January 1, 1998 and December 31, 2002. All costs associated with the patients' medical claims were adjusted to 2002 dollars using the medical component of Consumer Price Index. Patients were classified into three groups based on their drug regimen: atypical antipsychotics (ATYP), atypical antipsychotics plus mood stabilizers (ATYP + MS), and mood stabilizers only (MS). The Charlson comorbidity index was used to control for comorbid conditions. Using both Poisson and log-linear regression analyses, numbers of hospitalizations, emergency room (ER) visits, and outpatient visits, as well as treatment costs per enrolled month, were regressed on age, sex, medication regimen, and clinical comorbidities. The mean charge and reimbursement per patient-year were $12,797 and $6581, respectively. Of the tre...Continue Reading

References

Feb 1, 1992·Journal of Clinical Psychopharmacology·K T Brady, R B Lydiard
Feb 1, 1985·The American Journal of Psychiatry·H W KoenigsbergA M Cooper
Oct 3, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·G E Simon, J Unützer
Jun 4, 2002·The American Journal of Psychiatry·Carlos BlancoHarold Alan Pincus
Jul 13, 2002·Journal of Affective Disorders·Renee D Goodwin, Christina W Hoven
Aug 9, 2002·Journal of Affective Disorders·Michael A EscamillaNelson B Freimer
Aug 9, 2002·Journal of Affective Disorders·Jinmei LiGlen L Stimmel
Aug 22, 2002·Journal of Child and Adolescent Psychopharmacology·Janet WozniakStephen V Faraone
Aug 29, 2003·The American Journal of Psychiatry·Paul E KeckUNKNOWN Aripiprazole Study Group
Jan 20, 2004·The Journal of Clinical Psychiatry·Paul E Keck, Susan L McElroy
Mar 9, 2004·The Journal of Clinical Psychiatry·George I PapakostasMaurizio Fava
Jun 1, 2004·The American Journal of Psychiatry·Robert M A HirschfeldFred Grossman
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters

❮ Previous
Next ❯

Citations

Mar 5, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·J ZeidlerJ-M Graf von der Schulenburg
Sep 15, 2014·Comprehensive Psychiatry·Joshua ShapiroBenjamin I Goldstein
Jan 1, 2014·Bipolar Disorders·Katja Kleine-BuddeWulf Rössler
Sep 1, 2015·Epilepsy & Behavior : E&B·Sarah KnottRhys H Thomas
Mar 11, 2015·Revista de psiquiatrí́a y salud mental·Diego Hidalgo-MazzeiEduard Vieta
Nov 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alice Aita CacilhasFlávio Kapczinski
Mar 13, 2013·Journal of Affective Disorders·Andrea FagioliniAlessandro Rossi
Dec 24, 2014·Journal of Affective Disorders·Shefali MillerTerence A Ketter
Dec 28, 2016·Journal of Managed Care & Specialty Pharmacy·Andrea Salazar-OspinaLuis F Rodriguez
Jan 10, 2014·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Fábria ChiaraniMaurício Kunz
Jun 20, 2018·Bipolar Disorders·Anastasiya NestsiarovichChristophe G Lambert
Mar 1, 2012·Journal of Clinical Psychopharmacology·Jeffrey J Rakofsky, Boadie W Dunlop
Sep 29, 2020·ClinicoEconomics and Outcomes Research : CEOR·Leona BessonovaMauricio Tohen
Aug 2, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Fabiano A GomesFlávio Kapczinski
Jan 5, 2021·Journal of Medical Economics·Michael L GanzCharles Yonan
Sep 29, 2021·The Psychiatric Quarterly·Manuel Gonçalves-PinhoJoão Pedro Ribeiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here